PUBLISHER: KBV Research | PRODUCT CODE: 1261463
PUBLISHER: KBV Research | PRODUCT CODE: 1261463
North America Microbial Fermentation Technology Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Country and Growth Forecast, 2022 - 2028
The North America Microbial Fermentation Technology Market would witness market growth of 5.0% CAGR during the forecast period (2022-2028).
Solid-state fermentation (SSF) is used in various industries, including pharmaceuticals, textiles, food, etc., to grow metabolite bacteria on solid supports rather than liquid media. SSF differs from submerged fermentation (SmF) because it directly uses agricultural and industrial wastes as carbon sources and is more inexpensive. Microbiological components of SSF might be integrated indigenous microorganisms, single pure cultures, or mixed identifiable cultures. Mixed identifiable cultures are the most common form.
For example, some SSF technologies, like the production of tempeh and oncom, require the selective growth of organisms like molds that require low moisture levels to carry out fermentation with the help of extracellular enzymes synthesized by fermenting microorganisms. In SmF or submerged fermentation, the selected microorganisms are precisely grown in closed reactors with a high oxygen concentration and medium fermentation. The growth of the microorganisms occurs in a medium of liquid broth, supplemented with necessary nutrients to have superior cultivation of microorganisms.
Since this process requires a high moisture content, bacteria are typically used as a source. Over 3 to 4 days, submerged fermentation of 316 on cassava peel, Trichoderma viride ATCC 36, particularly on untreated cassava peel, increased the peel's crude protein content by 8-fold and its actual protein constituent by 22-fold. Most of the current enzyme businesses are driven by submerged fermentation (SmF), while solid-state fermentation (SSF) has been shown to achieve greater enzyme yields on a lab scale.
The US food and beverage industry is growing quickly in the region. According to the National Institute of Standards and Technology, the food and beverage industry ranks third among all manufacturing-related sectors in the United States' gross domestic product. Among the challenges faced by the food manufacturing sector are the Food Safety Modernization Act compliance, adopting sustainable packaging and production techniques, technological advancements, and other issues. Furthermore, due to the expansion of the region's food & beverage and healthcare industries, it is predicted that the adoption of microbial fermentation will rise significantly. Hence, the market in the region would grow in the ensuing years.
The US market dominated the North America Microbial Fermentation Technology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8,393.1 million by 2028. The Canada market is poised to grow at a CAGR of 7.4% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 6.4% during (2022 - 2028).
Based on Application, the market is segmented into Antibiotics, Recombinant Proteins, Enzymes, Monoclonal Antibodies, Probiotics Supplements, Vaccines, Biosimilars, Small Molecules and Others. Based on End User, the market is segmented into CMOs & CDMOs, Bio-Pharmaceutical Companies, Contract Research Organizations (CROs) and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Biocon Limited, BioVectra Inc. (H.I.G. Capital, LLC), Danone S.A., F. Hoffmann-La Roche Ltd., Koninklijke DSM N.V., Lonza Group AG, Novozymes A/S (Novo Holdings A/S), Corbion N.V., and Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN).
Scope of the Study
Market Segments covered in the Report:
By Application
- Antibiotics
- Recombinant Proteins
- Enzymes
- Monoclonal Antibodies
- Probiotics Supplements
- Vaccines
- Biosimilars
- Small Molecules
- Others
By End User
- CMOs & CDMOs
- Bio-Pharmaceutical Companies
- Contract Research Organizations (CROs)
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Biocon Limited
- BioVectra Inc. (H.I.G. Capital, LLC)
- Danone S.A.
- F. Hoffmann-La Roche Ltd.
- Koninklijke DSM N.V.
- Lonza Group AG
- Novozymes A/S (Novo Holdings A/S)
- Corbion N.V.
- Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Microbial Fermentation Technology Market, by Application
- 1.4.2 North America Microbial Fermentation Technology Market, by End User
- 1.4.3 North America Microbial Fermentation Technology Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Microbial Fermentation Technology Market
Chapter 4. North America Microbial Fermentation Technology Market by Application
- 4.1 North America Antibiotics Market by Country
- 4.2 North America Recombinant Proteins Market by Country
- 4.3 North America Enzymes Market by Country
- 4.4 North America Monoclonal Antibodies Market by Country
- 4.5 North America Probiotics Supplements Market by Country
- 4.6 North America Vaccines Market by Country
- 4.7 North America Biosimilars Market by Country
- 4.8 North America Small Molecules Market by Country
- 4.9 North America Others Market by Country
Chapter 5. North America Microbial Fermentation Technology Market by End-user
- 5.1 North America CMOs & CDMOs Market by Country
- 5.2 North America Bio-Pharmaceutical Companies Market by Country
- 5.3 North America Contract Research Organizations (CROs) Market by Country
- 5.4 North America Others Market by Country
Chapter 6. North America Microbial Fermentation Technology Market by Country
- 6.1 US Microbial Fermentation Technology Market
- 6.1.1 US Microbial Fermentation Technology Market by Application
- 6.1.2 US Microbial Fermentation Technology Market by End-user
- 6.2 Canada Microbial Fermentation Technology Market
- 6.2.1 Canada Microbial Fermentation Technology Market by Application
- 6.2.2 Canada Microbial Fermentation Technology Market by End-user
- 6.3 Mexico Microbial Fermentation Technology Market
- 6.3.1 Mexico Microbial Fermentation Technology Market by Application
- 6.3.2 Mexico Microbial Fermentation Technology Market by End-user
- 6.4 Rest of North America Microbial Fermentation Technology Market
- 6.4.1 Rest of North America Microbial Fermentation Technology Market by Application
- 6.4.2 Rest of North America Microbial Fermentation Technology Market by End-user
Chapter 7. Company Profiles
- 7.1 Biocon Limited
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expenses
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Acquisition and Mergers:
- 7.2 BioVectra Inc. (H.I.G. Capital, LLC)
- 7.2.1 Company Overview
- 7.2.2 Recent strategies and developments:
- 7.2.2.1 Partnerships, Collaborations, and Agreements:
- 7.2.2.2 Product Launches and Product Expansions:
- 7.2.2.3 Geographical Expansions:
- 7.3 Danone S.A.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Category and Regional Analysis
- 7.3.4 Recent strategies and developments:
- 7.3.4.1 Geographical Expansions:
- 7.4 F. Hoffmann-La Roche Ltd.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
- 7.5 Koninklijke DSM N.V.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Acquisition, Joint Venture and Mergers:
- 7.6 Lonza Group AG
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.7 Novozymes A/S (Novo Holdings A/S)
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Regional Analysis
- 7.7.4 Research & Development Expense
- 7.7.5 Recent strategies and developments:
- 7.7.5.1 Product Launches and Product Expansions:
- 7.8 Corbion N.V.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expense
- 7.9 Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)
- 7.9.1 Company Overview
LIST OF TABLES
- TABLE 1 North America Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 2 North America Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 3 North America Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 4 North America Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 5 North America Antibiotics Market by Country, 2018 - 2021, USD Million
- TABLE 6 North America Antibiotics Market by Country, 2022 - 2028, USD Million
- TABLE 7 North America Recombinant Proteins Market by Country, 2018 - 2021, USD Million
- TABLE 8 North America Recombinant Proteins Market by Country, 2022 - 2028, USD Million
- TABLE 9 North America Enzymes Market by Country, 2018 - 2021, USD Million
- TABLE 10 North America Enzymes Market by Country, 2022 - 2028, USD Million
- TABLE 11 North America Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
- TABLE 12 North America Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
- TABLE 13 North America Probiotics Supplements Market by Country, 2018 - 2021, USD Million
- TABLE 14 North America Probiotics Supplements Market by Country, 2022 - 2028, USD Million
- TABLE 15 North America Vaccines Market by Country, 2018 - 2021, USD Million
- TABLE 16 North America Vaccines Market by Country, 2022 - 2028, USD Million
- TABLE 17 North America Biosimilars Market by Country, 2018 - 2021, USD Million
- TABLE 18 North America Biosimilars Market by Country, 2022 - 2028, USD Million
- TABLE 19 North America Small Molecules Market by Country, 2018 - 2021, USD Million
- TABLE 20 North America Small Molecules Market by Country, 2022 - 2028, USD Million
- TABLE 21 North America Others Market by Country, 2018 - 2021, USD Million
- TABLE 22 North America Others Market by Country, 2022 - 2028, USD Million
- TABLE 23 North America Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 24 North America Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 25 North America CMOs & CDMOs Market by Country, 2018 - 2021, USD Million
- TABLE 26 North America CMOs & CDMOs Market by Country, 2022 - 2028, USD Million
- TABLE 27 North America Bio-Pharmaceutical Companies Market by Country, 2018 - 2021, USD Million
- TABLE 28 North America Bio-Pharmaceutical Companies Market by Country, 2022 - 2028, USD Million
- TABLE 29 North America Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
- TABLE 30 North America Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
- TABLE 31 North America Others Market by Country, 2018 - 2021, USD Million
- TABLE 32 North America Others Market by Country, 2022 - 2028, USD Million
- TABLE 33 North America Microbial Fermentation Technology Market by Country, 2018 - 2021, USD Million
- TABLE 34 North America Microbial Fermentation Technology Market by Country, 2022 - 2028, USD Million
- TABLE 35 US Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 36 US Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 37 US Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 38 US Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 39 US Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 40 US Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 41 Canada Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 42 Canada Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 43 Canada Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 44 Canada Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 45 Canada Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 46 Canada Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 47 Mexico Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 48 Mexico Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 49 Mexico Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 50 Mexico Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 51 Mexico Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 52 Mexico Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 53 Rest of North America Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 54 Rest of North America Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 55 Rest of North America Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 56 Rest of North America Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 57 Rest of North America Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 58 Rest of North America Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 59 Key Information - Biocon Limited
- TABLE 60 Key Information - BioVectra Inc
- TABLE 61 Key information - Danone S.A.
- TABLE 62 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
- TABLE 63 Key Information - Koninklijke DSM N.V.
- TABLE 64 Key Information - Lonza Group AG
- TABLE 65 key Information - Novozymes A/S
- TABLE 66 Key Information - Corbion N.V.
- TABLE 67 Key Information - BiOZEEN
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Recent strategies and developments: BioVectra Inc.
